A trial of caplacizumab in Japanese patients with acquired thrombotic thrombocytopenic purpura (aTTP)

Trial Identifier: EFC16297
Sponsor: Sanofi
Start Date: October 2019
Primary Completion Date: May 2021
Study Completion Date: May 2021
Condition: Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
JAPAN Iruma-Gun, JAPAN
JAPAN Kanazawa-Shi, JAPAN
JAPAN Kashihara-Shi, JAPAN
JAPAN Kawasaki-Shi, JAPAN
JAPAN Kitakyushu-Shi, JAPAN
JAPAN Kumamoto-Shi, JAPAN
JAPAN Kurashiki-Shi, JAPAN
JAPAN Kyoto-Shi, JAPAN
JAPAN Maebashi-Shi, JAPAN
JAPAN Nagoya, JAPAN
JAPAN Osaka-Shi, JAPAN
JAPAN Sendai-Shi, JAPAN